Gennex Laboratories has informed that in terms of the Letter of Offer dated July 16, 2022 and in accordance with the Basis of Allotment finalized in consultation with BSE (Designated Stock Exchange), the Lead Manager to the Issue and the Registrar to the Issue, the Rights Issue Committee of the Company has, at its meeting held on today, August 26, 2022, approved the allotment of 5,25,06,534 Rights Equity Shares of face value of Rs.1 each (Rs.0.25 paid-up) at a price of Rs.6 per Rights Equity Share including a share premium of Rs.5 per Rights Equity Share, of which Rs.1.50 per Rights Equity Share including a share premium of Rs.1.25 per Rights Equity Share has been paid up on application and the balance amount shall be payable on First and Final Call at such time as may be determined by the Board at its sole discretion.
The above information is a part of company’s filings submitted to BSE.